PRELUDE THERAPEUTICS INC Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
PRELUDE THERAPEUTICS INC (PRLD) reported Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes · last filed 2026-03-10
- PRELUDE THERAPEUTICS INC effective income tax rate reconciliation, state and local income taxes, percent for fiscal 2025 was 0.00%, a 100.00% decline from fiscal 2024.
- PRELUDE THERAPEUTICS INC effective income tax rate reconciliation, state and local income taxes, percent for fiscal 2024 was 6.60%, a 0.00% change from fiscal 2023.
- PRELUDE THERAPEUTICS INC effective income tax rate reconciliation, state and local income taxes, percent for fiscal 2023 was 6.60%, a 0.00% change from fiscal 2022.
- PRELUDE THERAPEUTICS INC effective income tax rate reconciliation, state and local income taxes, percent for fiscal 2022 was 6.60%, a 14.29% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent 12 month | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-10 | |
| 2024-12-31 | 6.60% 10-K · filed 2026-03-10 | |
| 2023-12-31 | 6.60% 10-K · filed 2025-03-10 | -6.60% 10-K · filed 2024-02-15 |
| 2022-12-31 | 6.60% 10-K · filed 2024-02-15 | |
| 2021-12-31 | 7.70% 10-K · filed 2023-03-15 | |
| 2020-12-31 | 6.50% 10-K · filed 2022-03-17 | |
| 2019-12-31 | 6.90% 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |